Total Returns (Price + Dividend) 
Resgen for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Is Resgen overvalued or undervalued?
As of 18 November 2025, the valuation grade for Resgen has moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company is currently assessed as undervalued. Key ratios supporting this assessment include a PE ratio of 20.29, an EV to EBITDA ratio of 10.32, and a PEG ratio of 0.95, all of which suggest that Resgen is priced favorably compared to its earnings growth potential. In comparison to its peers, Resgen's valuation metrics stand out. For instance, Larsen & Toubro has a much higher PE ratio of 34.3, and CG Power & Industries is deemed very expensive with a PE of 108.1. This places Resgen in a more attractive position relative to its industry, particularly given its solid ROCE of 20.21% and ROE of 12.95%. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 33.99% compared to the Sensex's gain of 8.36%, the underlyi...
Read MoreHow has been the historical performance of Resgen?
Answer: The historical performance of Resgen shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025. Breakdown: Resgen's net sales have increased dramatically from 0.02 crore in March 2021 to 65.16 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.02 crore in March 2021 to 65.16 crore in March 2025. The company's total expenditure also grew, from 0.01 crore in March 2021 to 49.78 crore in March 2025, with raw material costs being the largest component. Operating profit (PBDIT) has shown consistent improvement, reaching 15.38 crore in March 2025, up from just 0.01 crore in March 2021. Profit before tax increased from 0.01 crore in March 2021 to 11.14 crore in March 2025, and profit after tax rose to 7.98 crore in March 2025 from 0.01 crore in March 2021. The company's total as...
Read More Announcements 
Outcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEApproval of the unaudited Financial Results for the half year ended on 30th September 2025
Board Meeting Outcome for Outcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEOutcome of Board Meeting held for consideration and approval of the unaudited Financial Results for the half year ended 30th September 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025 And Other Matters.
10-Nov-2025 | Source : BSEResgen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve The unaudited Financial Results for the half year ended 30th September 2025 and other matters.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Karan Atul Bora . (65.18%)
Comfort Capital Private Limited (1.31%)
26.2%
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -4.05% vs 53.64% in Mar 2025
Growth in half year ended Sep 2025 is -2.66% vs 7.81% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 43.21% vs 92.96% in Mar 2024
YoY Growth in year ended Mar 2025 is 21.46% vs 57.55% in Mar 2024






